[Home ] [Archive]    
:: Main Online Submission Archive Current Issue In Press ::
:: Volume 13, Issue 5 (October 2011) ::
ZJRMS 2011, 13(5): 1-7 Back to browse issues page
Epigenetic mechanisms in the initiation of hematological malignancies
Ali Maleki, Saeid Kaviani , Mehrdad Noruzinia, Majid Farshdoosti-Hagh, Zeinab Kaviani, Kamran Mansouri
, kavianis@modares.ac.ir
Abstract:   (12840 Views)
Normal 0 false false false EN-US X-NONE AR-SA

Background: Cancer development is not restricted to the genetic changes, but also to epigenetic changes. Epigenetic processes are very important in the development of hematological malignancies. The main epigenetic alterations are aberrations in DNA methylation, post-translational modifications of histones, chromatin remodeling and microRNAs patterns, and these are associated with tumor genesis. All the various cellular pathways contributing to the neoplastic phenotype are affected by epigenetic genes in cancer. These pathways can be explored as biomarkers in clinical use for early detection of disease, malignancy classification and response to treatment with classical chemotherapy agents and epigenetic drugs.

Materials and Method: A literature review was performed using PUBMED from 1985 to 2008. Cross referencing of discovered articles was also reviewed.

Results: In chronic lymphocytic leukemia, regional hypermethylation of gene promoters leads to gene silencing. Many of these genes have tumor suppressor phenotypes. In myelodysplastic syndrome (MDS), CDKN2B (alias, P15), a cyclin-dependent kinase inhibitor that negatively regulates the cell cycle, has been shown to be hypermethylated in marrow stem (CD34+) cells in patients with MDS. At present both Vidaza and Decitabine (DNA methyltransferase inhibitors) are approved for the treatment of MDS.

Conclusion: Unlike mutations or deletions, DNA hypermethylation and histone deacetylation are potentially reversible by pharmacological inhibition, therefore those epigenetic changes have been recognized as promising novel therapeutic targets in hematopoietic malignances. In this review, we discussed molecular mechanisms of epigenetics, epigenetic changes in hematological malignancies and epigenetic based treatments. [ZJRMS, 13(5):1-7]

Keywords: Epigenetic, hematological neoplasms, methylation, histone
Full-Text [PDF 221 kb]   (8828 Downloads)    
Type of Study: Review Article | Subject: Oncology
* Corresponding Author Address: MSc of Hematology, Medical Biology Research Center Kermanshah University of Medical Sciences, Kermanshah, Iran.
Send email to the article author

Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Maleki A, Kaviani S, Noruzinia M, Farshdoosti-Hagh M, Kaviani Z, Mansouri K. Epigenetic mechanisms in the initiation of hematological malignancies . ZJRMS. 2011; 13 (5) :1-7
URL: http://zjrms.ir/article-1-1342-en.html

Volume 13, Issue 5 (October 2011) Back to browse issues page
Zahedan Journal of Research in Medical Sciences
Persian site map - English site map - Created in 0.06 seconds with 32 queries by YEKTAWEB 3921